Retour sur lavenir.net
   AB INBEV 68.620 € (+0,50 %)     ONTEX GROUP 2.725 € (-2,15 %)     AGEAS 75.200 € (+0,60 %)     VASTNED 28.500 € (0,00 %)     KBC 132.650 € (+0,19 %)     TUBIZE-FIN 184.400 € (-1,13 %)     RECTICEL 13.460 € (-1,90 %)     ARGENX SE 877.200 € (-2,01 %)     GIMV 44.200 € (-0,56 %)     KBC ANCORA 94.400 € (+0,21 %)     ACCENTIS 0.026 € (-1,92 %)     WDP 21.120 € (-1,03 %)     ACKERMANS V.HAAREN 269.400 € (-3,51 %)     XIOR 27.050 € (-0,18 %)     KINEPOLIS GROUP 46.650 € (+0,76 %)     AEDIFICA 67.700 € (-0,95 %)     SYENSQO 81.800 € (+0,55 %)     ROULARTA 12.300 € (-3,53 %)     IBA 16.480 € (-2,14 %)     ATENOR 1.280 € (-0,39 %)     MONTEA 64.900 € (-0,92 %)     EVS 29.800 € (-1,49 %)     TITAN S.A. 53.700 € (+0,19 %)     MELEXIS 66.300 € (+0,15 %)     AZELIS GROUP 12.250 € (-0,16 %)     DEME GROUP 175.200 € (-1,68 %)     FLUXYS BELGIUM D 22.900 € (+1,33 %)     UCB 215.400 € (-0,51 %)     VGP 80.300 € (-1,35 %)     BPOST 1.300 € (-0,61 %)     VIOHALCO 16.700 € (0,00 %)     SOFINA 248.400 € (0,00 %)     BEKAERT 39.100 € (+1,03 %)     D'IETEREN GROUP 177.700 € (+0,62 %)     GBL 73.750 € (-0,14 %)     UMICORE 23.340 € (-1,60 %)     ABO GROUP 3.900 € (-2,50 %)     EKOPAK 4.000 € (0,00 %)     SOLVAY 26.020 € (+1,01 %)     PROXIMUS 6.330 € (-0,31 %)     BARCO 7.920 € (-0,13 %)     BQUE NAT. BELGIQUE 378.000 € (+0,27 %)     CARE PROPERTY INV. 12.060 € (-0,82 %)     NYRSTAR 0.058 € (-3,33 %)     SIPEF 104.000 € (+0,97 %)     COLRUYT 38.960 € (-0,05 %)     FAGRON 22.400 € (-0,44 %)     SHURGARD 22.750 € (-1,09 %)     CENERGY 22.860 € (+0,53 %)     AGFA-GEVAERT 0.466 € (+0,32 %)     ASCENCIO 51.500 € (-0,39 %)     RETAIL ESTATES 65.500 € (-0,46 %)     CMB.TECH 15.860 € (-0,25 %)     ORANGE BELGIUM 22.200 € (+0,91 %)     ONWARD MEDICAL 2.445 € (-1,01 %)     CELYAD ONCOLOGY 0.261 € (0,00 %)     TINC 11.200 € (-0,36 %)     JENSEN-GROUP 74.200 € (-0,54 %)     NYXOAH 1.440 € (0,00 %)     BIOTALYS 2.540 € (+1,20 %)  
   STIF 47.440 € (-0,13 %)     HAVAS 18.500 € (-0,54 %)     74SOFTWARE 40.700 € (+0,99 %)     AYVENS 11.110 € (+0,73 %)     ATON 0.017 € (+2,47 %)     OPMOBILITY 12.730 € (+0,79 %)     FERROVIAL 50.400 € (-0,55 %)     CRCAM ILLE-VIL.CCI 116.500 € (-1,32 %)     WOLTERS KLUWER 70.420 € (+0,28 %)     IMERYS 24.660 € (-0,08 %)     VINCI 114.550 € (+0,17 %)     MERCIALYS 11.140 € (0,00 %)     SECHE ENVIRONNEM. 80.700 € (-0,98 %)     B.COM.PORTUGUES 1.125 € (+0,45 %)     VEOLIA ENVIRON. 32.870 € (+0,06 %)     KERING 253.550 € (-0,26 %)     SAFRAN 342.400 € (-0,52 %)     EIFFAGE 109.800 € (+0,09 %)     HERMES INTL 1 598.500 € (+0,03 %)     AEGON 8.028 € (+0,02 %)     VALERIO TX 0.731 € (-5,43 %)     NEXANS 140.500 € (-1,47 %)     RENAULT 29.560 € (+0,44 %)     KLEPIERRE 37.560 € (-0,53 %)     SOLUTIONS 30 SE 0.582 € (-1,02 %)     ING GROEP N.V. 30.585 € (+0,41 %)     BNP PARIBAS ACT.A 103.420 € (+0,84 %)     ALSTOM 16.460 € (+0,40 %)     SCHNEIDER ELECTRIC 299.400 € (-0,78 %)     NX FILTRATION 3.180 € (-2,60 %)     Vusion 130.500 € (+0,31 %)     BE SEMICONDUCTOR 196.600 € (-0,46 %)     IMCD 99.400 € (+0,26 %)     TELEPERFORMANCE 69.420 € (-1,34 %)     WORLDLINE 13.510 € (-3,35 %)     ALFEN 11.590 € (-0,94 %)     AIR LIQUIDE 170.540 € (+0,44 %)     ARVERNE GROUP 8.100 € (+1,25 %)     DBT 0.060 € (+33,33 %)     SANOFI 77.200 € (-0,06 %)     SOCIETE GENERALE 73.310 € (+1,33 %)     S.E.B. 59.450 € (+0,42 %)     STMICROELECTRONICS 43.205 € (-0,36 %)     BIOPHYTIS 0.070 € (+33,59 %)     ASR NEDERLAND 72.560 € (+0,22 %)     LVMH 458.900 € (+0,16 %)     North Atlantic En. 87.600 € (+8,96 %)     STELLANTIS NV 4.708 € (+0,57 %)     ASM INTERNATIONAL 818.000 € (-0,94 %)     ABN AMRO BANK N.V. 41.780 € (+0,24 %)     CREDIT AGRICOLE 18.560 € (+0,65 %)     HEIJMANS KON 88.600 € (-1,06 %)     SAINT GOBAIN 80.240 € (+0,58 %)     SHELL PLC 39.425 € (+0,72 %)     ABIVAX 96.750 € (-0,67 %)     TECHNIP ENERGIES 30.240 € (+0,13 %)     UNIBAIL-RODAMCO-WE 98.040 € (-0,93 %)     UBISOFT ENTERTAIN 5.176 € (-2,27 %)     VALLOUREC 18.140 € (+2,14 %)     GENFIT 14.000 € (-2,64 %)  
News Réglementées
31/08/2026 06:30

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management

EQS-News: Huawei / Key word(s): Miscellaneous/Product Launch
HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management

31.08.2026 / 06:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


MUNICH, Aug. 31, 2026 /PRNewswire/ -- The European Society of Cardiology Congress (ESC Congress 2026), one of the world's most influential academic gatherings in cardiovascular medicine, officially kicked off today in Munich, Germany. Huawei showcased its latest innovations in health and fitness, offering an exclusive sneak peek at its next-generation ambulatory blood pressure monitor, the HUAWEI WATCH D3, ahead of its official launch at the Huawei Innovative Product Launch in Munich on 2 September. Bridging cutting-edge academic research with everyday consumer technology, Huawei continues to demonstrate its commitment to open collaboration, connecting pioneering research with products that reshape people's daily lives.

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026

A Legacy of Persistence, A Leap Forward

Huawei's journey in blood pressure monitoring technology traces back to 2014, when the company first ventured into the sports and health domain. Over the past decade, Huawei has steadily advanced wearable health monitoring technologies to drive the evolution of the industry, from dynamic heart rate monitoring and SpO₂ tracking to ECG collection, and ultimately to blood pressure measurement.

In 2021, Huawei launched its first wrist-based ambulatory blood pressure recorder, the HUAWEI WATCH D. This device brought medical-grade blood pressure measurement capabilities to people's wrists for the first time, securing medical device certification in multiple countries and regions, including China and the European Union. In 2024, the HUAWEI WATCH D2 was officially released, introducing 24-hour ambulatory blood pressure monitoring and redefining blood pressure management.

In 2026, Huawei is set to unveil its latest achievement in blood pressure health—the next-generation HUAWEI WATCH D series. As the latest wrist-based ambulatory blood pressure recorder, the HUAWEI WATCH D3 achieves further breakthroughs across more blood pressure measurement scenarios while delivering more comprehensive health protection.

Lightweight Design, Professionalism Meets Style

To enhance comfort during extended wear, the HUAWEI WATCH D3 features further refinements in device thickness and strap weight. It will be available in three fashionable colour options inspired by "nature's healing"—designed not only for comfort but also as a stylish everyday accessory, seamlessly blending in with diverse lifestyles and sports scenarios.

Broader Scenarios, Richer Health Insights

The HUAWEI WATCH D3 ensures accurate blood pressure measurement at elevated heart rates. It accurately records blood pressure data before and after exercise, provides recommendations on appropriate exercise intensity, and helps users develop good fitness habits. Furthermore, the HUAWEI WATCH D3 has been certified by CE MDR in the European Union, with its certification scope covering single blood pressure measurements, ambulatory blood pressure monitoring, and pre- and post-exercise blood pressure measurements. Newly added features include blood pressure measurement reminders for high-altitude environments and sudden temperature changes, ensuring users never miss a critical monitoring check.

Beyond its core blood pressure monitoring capabilities, the HUAWEI WATCH D3 also offers richer Health Glance metrics and health studies, alongside continuous improvements in sleep and emotional wellbeing tracking[1]. Further details on specific applications will be announced in due course.

Stay tuned to Huawei's official channels for information on the official launch date, pricing, and full specifications of the HUAWEI WATCH D3.

[1] The data collected by Health Glance features and health studies is for reference only, and should not be used for diagnosis or treatment.

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/huawei-watch-d3-makes-early-debut-at-esc-congress-2026-a-new-era-in-wrist-based-blood-pressure-management-302864640.html

rt.gif?NewsItemId=EN36719&Transmission_Id=202608310023PR_NEWS_EURO_ND__EN36719&DateId=20260831


31.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2390688  31.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière